Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2018, Article ID 4263520, 11 pages
https://doi.org/10.1155/2018/4263520
Research Article

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

1Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China
2The Affiliated Aoyang Hospital of Jiangsu University, Zhangjiagang, Jiangsu 215600, China
3Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China

Correspondence should be addressed to Liantao Li; nc.ude.umhzx@oatnailil and Junnian Zheng; nc.ude.umhzx@gnehznj

Received 19 April 2018; Accepted 17 August 2018; Published 15 October 2018

Academic Editor: Lei Zhao

Copyright © 2018 Qing Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Qing Zhang, Haixu Zhang, Jiage Ding, et al., “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models,” Journal of Immunology Research, vol. 2018, Article ID 4263520, 11 pages, 2018. https://doi.org/10.1155/2018/4263520.